ME/CFS South Australia Inc: Zegami Joins Team Of Medical Researchers To Help Find The Cause Of ME/CFS And Ultimately A Cure

ME/CFS SOUTH AUSTRALIA INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 322,
Modbury North,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Zegami Joins Team Of Medical Researchers To Help Find The Cause Of ME/CFS And Ultimately A Cure

Friday 12 June 2020

ZEGAMI JOINS TEAM OF MEDICAL RESEARCHERS TO HELP FIND THE CAUSE OF ME/CHRONIC FATIGUE SYNDROME AND ULTIMATELY A CURE

Zegami, the Oxford University data visualisation spin-out, has joined an international team of medical researchers to try and find the cause of Myalgic Encephalomyelitis (ME) or Chronic Fatigue Syndrome (CFS). This could then help in the development of the first ever medical test for the condition, new treatments or even to find a cure. The work could also help researchers studying other medical conditions that have a fatigue symptom including cancer, strokes, Parkinson's Disease and Multiple Sclerosis.

ME/CFS affects 20 million people worldwide, but it is not clear what causes it. Complex and variable symptoms make it difficult to diagnose and only 5% of patients make a full recovery. Research into the causes has been limited due to a lack of funding, but the recent identification of high levels of L-form bacteria in the blood of patients suggests they may play a role in condition.

The new research project will be the largest of its kind in Europe, involving three ME/CFS research centres (Oxford, Bydgoszcz (Poland), and Valencia) over a four to five-year period. The team, led by Dr Karl Morten from the Department of Women's and Reproductive Health, University of Oxford, has secured funding worth $750,000 from SoftCell Biologicals, who have developed a patent-pending protocol to culture and examine hidden bacteria in the circulatory system, and is looking to raise an additional £1.6 million.